---
title: "Lyell Immunopharma, Inc. Stock 12‑Month Price Target Cut to $37.17, Implies 150% Upside"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/288593281.md"
description: "Analysts have lowered Lyell Immunopharma's average 12-month price target from $42.20 to $37.17, based on estimates from six covering analysts with forecasts ranging from $12 to $49. Despite the cut, the consensus rating remains 'Buy' (5 Buys, 1 Sell). Based on the June 2 closing price, the new target still implies approximately 150% potential upside."
datetime: "2026-06-03T14:20:07.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/288593281.md)
  - [en](https://longbridge.com/en/news/288593281.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/288593281.md)
generator: "portal-rs"
---

# Lyell Immunopharma, Inc. Stock 12‑Month Price Target Cut to $37.17, Implies 150% Upside

-   According to estimates from 6 analysts, Lyell Immunopharma, Inc. stock's average price target has fallen from $42.2 to $37.17, with forecasts ranging from $12 to $49 per share
-   Based on the Jun. 2 closing price, the updated target implies approximately 150% potential upside
-   Consensus rating remains at “Buy” across 6 covering analysts, with 5 Buys, 0 Holds and 1 Sells

Explore more price target data and ratings for Lyell Immunopharma, Inc. on the , and track all previous and future analyst recommendations for Lyell Immunopharma, Inc. in the dedicated News Flow.

**Disclaimer**

Select reference data provided by FactSet. Copyright © 2026 FactSet Research Systems Inc. This information is not a recommendation for what you should do personally and does not constitute investment advice.

### Related Stocks

- [LYEL.US](https://longbridge.com/en/quote/LYEL.US.md)

## Related News & Research

- [Mundoro Capital Inc. GAAP EPS of $0.00](https://longbridge.com/en/news/297553342.md)
- [TenX Protocols Inc. reports Q1 results](https://longbridge.com/en/news/297560433.md)
- [What Bollinger Bands Are Saying About Stocks Right Now](https://longbridge.com/en/news/297783105.md)
- [This Ormat Technologies Analyst Is No Longer Bearish; Here Are Top 3 Upgrades For Friday](https://longbridge.com/en/news/298059925.md)
- [Paycom (PAYC) Stock Still Looks Below Fair Value While Earnings Look Fair](https://longbridge.com/en/news/297652209.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**